Trump announces lower prices, Medicare coverage for popular weight-loss drugs
Healthcare,Medicare,Drugs,Weight Loss,Obesity And Malnutrition,Drug Prices
From the Left
AllSides Media Bias Rating: Lean Left
President Donald Trump announced a deal Thursday, Nov. 6 with drugmakers Eli Lilly and Novo Nordisk to cut prices of their popular weight-loss drugs and expand Medicare coverage of these medications for older adults.
The negotiated deals will allow Medicare and Medicaid coverage for Lilly's Zepbound and Novo's Wegovy, and consumers will be able to purchase drugs at discounted prices through the federal government's direct-to-consumer website, TrumpRx, which will launch in 2026...
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
More News about Healthcare
News from the Left
News from the Center
News from the Right
No. 2 DOJ official slams judge for blocking vaccine changes hours after appeals court overturned him
Just The News